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Abstract 
Background: The Cardiac Depression Scale (CDS) is a disease-specific instrument for 
measuring depression in cardiac patients. This study was designed to validate the CDS in an 
Iranian population. 
Methods:  Translation and back translation of the 26- Item CDS scale was performed using 
recommended procedures. The Iranian translation of the CDS (I-CDS) was administered to 
261 individuals in Iran, concurrently with the Beck Depression Inventory. The factor structure 
of the I-CDS was examined using exploratory factor analysis procedures to enable 
comparison with previous psychometric evaluation of the CDS. Receiver operating 
characteristic (ROC) curves were used to examine the ability of the I-CDS to discriminate 
between categories of depression. 
Results: First-order exploratory factor analysis uncovered two robust factors, consistent with 
the second-order dimensions originally reported by the developers of this instrument. 
Cronbach’s alpha was 0.88 for the total 26-item I-CDS, indicating satisfactory internal 
consistency of the I-CDS. Intercorrelation between the total scores for the I-CDS and BDI 
was 0 .62 (P< .001). For the I-CDS cut off of 90, the sensitivity was 85%, and specificity was 
61% with a computed area under the curve (AUC) of .81 (95% CI, .76- .87). For the I-CDS 
cut off of 100, the sensitivity was 81% and specificity was 63% with a computed AUC of .81 
(95% CI, .76- .87).  
Conclusion: This validation study of the Iranian version of the CDS proved that it is an 
acceptable, a reliable and valid measure of depression in cardiac patients. 
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Introduction 
Depression, particularly mild depression, is common among those hospitalised with coronary 
heart disease (CHD) and has been estimated to affect about one-third of these individuals 
(Astin, Jones, & Thompson, 2005; Lespérance & Frasure-Smith, 2000). In one long-term 
follow-up study on mortality risk in people with heart disease, mild depression was shown to 
be associated with 38% higher adjusted cardiac mortality risk (Barefoot et al., 1996). There is 
a dose response effect between untreated depression and health outcomes for people with 
CHD (Denollet, Vaes, & Brutsaert, 2000). Of significance, individuals with CHD who are 
depressed are less likely to adhere to recommended lifestyle changes following an acute 
coronary event (Ziegelstein et al., 2000), and are at higher risk of recurrent cardiac events 
(Rozanski, Blumenthal, & Kaplan, 1999). As a consequence, there is an increasing 
recognition of the importance of screening for depression in individuals with heart disease 
(Lichtman et al., 2008). The prevalence of depression in Iranian cardiac patients has not been 
reported, however, among the general population in Iran, the prevalence of minor depressive 
disorder, dysthymia and major depressive disorder was 5%, 2.5%, and 1% respectively 
(Modabernia, Tehrani, Fallahi, Shirazi, & Modabbernia, 2008). 
Three large randomised trials have demonstrated that depression in people with heart disease 
can be improved by specific treatments (Berkman et al., 2003; Glassman et al., 2002; 
Lespérance et al., 2007).  In spite of the targeted and conceptually congruent interventions, 
these studies have failed to demonstrate any reduction of cardiac events, particularly cardiac 
mortality (Berkman et al., 2003; Glassman et al., 2002; Lespérance et al., 2007). One 
explanation for these conflicting results may be the way depression was measured. A range of 
generic depression assessment tools was used with varying sensitivities in detecting 
depression in people with heart disease where cardiac-related symptoms, such as fatigue and 
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lethargy, may emulate depressive symptoms. Hence, depression among individuals with heart 
disease is under-detected as somatic symptoms of depression are commonly attributed to 
cardiac problems instead of depression (Thornton, 2001). 
Therefore, a disease-specific depression scale capable of accurately assessing depression 
among cardiac patients is a particularly useful assessment tool to ensure these patients receive 
appropriate management. The Cardiac Depression Scale (CDS), developed specifically to 
measure adjustment disorder with depressed mood among people with heart disease,(Hare & 
Davis, 1996) has been shown to be more sensitive than generic depression scales such as the 
Beck Depression Inventory (BDI) in identifying depression, particularly in those with mild or 
subclinical depression {1,  #6}. The BDI, developed to detect, assess, and monitor changes in 
depressive symptoms among psychiatric patients, gives a skewed distribution on scores in 
people with heart disease (Hare & Davis, 1996). The CDS and BDI both have excellent 
properties for detecting major depression in cardiac patients. However, the CDS is more 
accurate for detecting subtle changes and may be useful for monitoring changes across the 
illness trajectory (Frasure-Smith & Lespérance, 2006). A CDS cut off score of ≥ 100 provides 
88% sensitivity and 84% specificity for detecting major depression. A cut off score of 90 
provides 84% sensitivity and 78% specificity for detecting minor depression (Wise, Harris, & 
Carter, 2006).  
The CDS has been validated on samples of ambulatory cardiac patients in Australia (Hare & 
Davis, 1996; Wise et al., 2006), and replicated in the United Kingdom (Birks, Roebuck, & 
Thompson, 2004). The cross-cultural robustness of the CDS has been demonstrated on a 
German version of this measure on a sample of participants recruited from an inpatient 
cardiac rehabilitation setting (Hare, Meyer, & McBurney, 2000), and a Chinese version on a 
sample of inpatient cardiac patients (Wang, Thompson, Chairc, & Hare, 2008). To date, factor 
 
  5 
analysis studies of the CDS have yielded slightly different findings. Although the original 
study uncovered 2 dimensions using second-order factor analysis (Hare & Davis, 1996), both 
Birks et al. (2004) and Wise et al (2006) concluded that a one-factor solution was a better fit 
to their data using second-order factor analysis. 
The purpose of this study was to develop an Iranian translation of the CDS (I-CDS) and to 
cross-validate this scale on Iranian inpatients with cardiovascular disease. In particular, the 
study aimed to explore the factor structure of the I-CDS, using exploratory factor analysis 
procedures to facilitate comparison with previous psychometric studies of the CDS. The 
reliability and the concurrent validity of the I-CDS were also examined, the latter by 
examining the relationship between I-CDS and the BDI. 
Methods 
Study setting 
This study was conducted in the Province of Azerbaijan, north-west of Iran, where people 
mainly speak Azeri; however, majority of them can also speak, read and write in Farsi, the 
official language of the country.  
Sample 
The study participants were recruited from patients admitted to the intermediate cardiac care 
unit and cardiac surgical unit of a teaching heart hospital in Iran. Using non-random sampling 
method, 261 patients admitted to the intermediate cardiac care unit and cardiac surgical unit 
of a university-affiliated hospital were recruited from October 2007 to December 2007. The 
hospital is considered to be the biggest cardiac hospital in Tabriz and the north-west of Iran. 
Four patients refused to participate in the study mainly due to poor health. All participants had 
a diagnosis of heart disease including myocardial infarction (25%), unstable angina (38%), 
heart failure (17%), angioplasty and/or cardiac surgery (20%), as documented by a 
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cardiologist in their medical records. This study received ethics clearance from both the 
university and the hospital where the study was undertaken. 
Materials 
Beck Depression Inventory 
The Beck Depression Inventory (BDI) is a 21-question multiple choice self-report inventory, 
measuring the symptoms of depression using scores from 0 to 3. The BDI is perhaps one of 
the most commonly used screening tools for depression, and has been widely used on a 
variety of populations with diverse diseases including heart disease. The BDI is a reliable and 
valid scale, with internal consistency of .86 for psychiatric patients and .81 for non-
psychiatric populations (Beck, Steer, & Carbin, 1988a). The advantage of the BDI is the 
possibility of comparing depression scores in diverse populations and diseases (Beck et al., 
1988a). The BDI has previously been validated in Iranian populations, with high internal 
consistency (Cronbach's alpha = .87) and acceptable test-retest reliability (r = .74) 
(Ghassemzadeh, Mojtabai, Karamghadiri, & Ebrahimkhani, 2005). 
Cardiac Depression Scale 
The CDS is a 26-item self-rating scale, measuring depression specifically in individuals with 
diagnosed heart disease using a Likert scale of 1 to 7. The CDS was originally developed in 
the English language and was validated in an Australian population, with a reliability 
coefficient of .9 and correlation with the BDI of  .73 (Hare & Davis, 1996). The original CDS 
was reported to yield two dimensions and seven subscales including sleep, anhedonia, 
uncertainty, mood, cognition, hopelessness and inactivity (Hare & Davis, 1996). 
Translation and back-translation of the I-CDS 
Translation and back-translation of the I-CDS were conducted following the guidelines 
suggested by Guillemin and colleagues (Guillemin, Bombardier, & Beaton, 1993). The 26 
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items of the CDS were translated into Farsi by two clinicians with experience in the 
translation of English texts. The back-translation was performed by a bilingual expert who 
had not seen the scale before. The final Farsi version of the CDS was achieved following 
repeated translation and back-translation procedures until all bilingual experts in the research 
team confirmed equivalence of the English and Farsi versions. In line with the original CDS 
version, the final 26-item I-CDS contains 7 reverse-scored items. 
Procedure 
A research assistant trained in instrument administration explained the study in the 
participants’ first language and obtained verbal consent from the participants. A verbal 
consent was obtained from both participants and parents if the participant was under 18 years 
old. Participants were then asked to complete the I-CDS and the BDI independently. The 
questionnaires were collected a few days later. In instances where a participant was unable to 
read, the research assistant read the questionnaire out loud to the participant to obtain their 
responses. 
Data analysis 
To determine the factor structure of the I-CDS, exploratory factor analyses were used. 
Although confirmatory factor analysis is recommended for validated scales such as the CDS 
(Henson & Roberts, 2006), the conflicting findings on the factor structures warranted further 
exploratory validation of this instrument. Hence, we conducted first-order exploratory factor 
analysis to examine the factor structure of the I-CDS using previously reported extraction 
procedures (Birks et al., 2004; Hare & Davis, 1996; Wise et al., 2006). A factor loading of .3 
or greater, indicating a shared variance with the factor of at least 10% was used as the cut off 
for significant loading. Internal consistency determined by Cronbach’s alpha was used to 
assess the reliability of I-CDS. Receiver-operating characteristic (ROC) curve was used as a 
graphical tool for assessing the capability of I-CDS as a screening tool to discriminate 
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between those with or without depressive symptoms. Sensitivity, specificity and area under 
ROC curve were performed using the BDI as the comparison measure. Total I-CDS and the 
BDI scores with recommended cut off scores of 90 for I-CDS and 10 for BDI for mild 
depression, and 100 for I-CDS and 18 for BDI for severe depressive symptoms were used 
(Beck, Steer, & Garbin, 1988b; Grace et al., 2005; Wise et al., 2006). 
Results 
Of the 261 participants completing the survey, about two-thirds (67.8%) were males and 
82.6% married. The mean age was 52 (SD=13.8 years; range 14-84) and approximately 90% 
of the participants had at least primary schooling. Nearly all of the participants self-declared 
their religion to be Muslims (96.2%), and 40% had a previous diagnosis of heart disease. 
The mean total I-CDS score was 101.37 (SD=25.72; median 102; range 40-173), with 
skewness of -.09 and kurtosis of -.18, and it fulfilled the Kolmogorov-Smirnov test of normal 
distribution (p= .54). In comparison, the mean total BDI score was 15.61 (SD=10.77; median 
13; range 0-57), with skewness of .91 and kurtosis of .53, and it failed the Kolmogorov-
Smirnov test of normal distribution (p< .001).  
Factor structures 
In order to reproduce the CDS factor structure reported previously, we replicated the factor 
analysis procedures used by Wise et al.(Wise et al., 2006), Birks et al.(Birks et al., 2004) and 
Hare et al.(Hare & Davis, 1996) Using the ‘eigenvalues of greater than one’ criterion for 
factor extraction, seven factors were extracted that accounted for 61% of variance. Using the 
maximum likelihood factor extraction with oblique rotation as reported in the original 
validation (Hare & Davis, 1996),  items of all subscales had factor loadings above the  .3 
threshold, but cross factor loadings were detected in 3 of the 7 subscales, which were mood, 
anhedonia and uncertainty.  
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Using Catell’s scree plot analysis to determine the number of factors to retain, six factors 
were extracted accounting for 57% of the variance, which is consistent with the number of 
factors reported by Wise et al.(Wise et al., 2006). Applying the same procedure as Wise et 
al.(Wise et al., 2006) of principal components with orthogonal (varimax) rotation, there were 
shared variance and cross-loadings of items, particularly in 2 subscales, fear and mood (Table 
1). 
In keeping with the procedure reported by Birks et al.(Birks et al., 2004) a one-factor solution 
using principal axis factoring extraction uncovered 24 items with a factor loading that were 
above the .3 cut off. Two items that failed to reach salient factor loading (i.e. less than .3) 
were: Item 15 ‘My mind is as fast and alert as always’ and item 2 ‘My concentration is as 
good as it ever was’. 
The authors of the scale suggest that the CDS consists of two underlying dimensions and 7 
subscales. A first-order two-factor extraction, using the maximum likelihood factor extraction 
with oblique rotation yielded the same two structure of significant factor loadings ( .30 to  
.70) similar to the two dimensions previously reported in the original validation (Hare & 
Davis, 1996). The first factor (dimension A) consists of items from Hare & Davis (Hare & 
Davis, 1996) original 5 subscales (sleep, uncertainty, mood, hopelessness and inactivity), and 
the second factor (dimension B) consists of a total of 7 items from the original remaining 2 
subscales: anhedonia and cognition (Table 2). 
Cronbach’s alpha was .88 for the total 26-item I-CDS, indicating satisfactory internal 
consistency of the I-CDS. Cronbach’s alpha for each of the factors were .88 for dimension A 
and .70 for dimension B. Age and scores of the dimension A (r= .14, P= .029) and dimension 
B (r= .15, P= .023) correlated weakly, demonstrating that these scores to a great extent are 
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independent of age with is consistent with the report of the original study (Hare & Davis, 
1996).  
Comparisons between I-CDS and BDI 
Intercorrelation between the total scores for the I-CDS and BDI was .62 (P< .001). Using the 
recommended BDI cut off score of 10 for mild to moderate depression and 18 for severe 
depression, two receiver operating characteristic (ROC) curves were used to examine the 
ability of the I-CDS to discriminate between the two categories of depression. For the I-CDS 
cut off of 90, the sensitivity was 85%, and specificity was 61% with a computed area under 
the curve (AUC) of .81 (95% CI, .76- .87) when discriminating mild and moderate depression 
from individuals without depressive symptoms. For the I-CDS cut off of 100, the sensitivity 
was 81%, and specificity was 63% with a computed AUC of .81 (95% CI, .76- .87) (Table 3, 
Figure 1). The percentages of patients with mild/moderate and severe depression according to 
the I-CDS and BDI are presented in Table 4. 
Discussion 
The findings presented above provided validation of the I-CDS and the suitability of the 
measure in the Iranian cardiac population. Compared to the previous studies, the higher I-
CDS scores and BDI scores may be partially explained by differences in study settings.  
Achieving normative data in particular populations is important and may need to be 
considered within a context of acculturation and cultural competence (Davidson et al., 2007). 
These observations raise an important question as to the potential influence of culture and 
socialisation in the expression of depressive symptoms (Kleinman, 2004) and cultural 
tendencies in response styles (Hamamura, Heine, & Paulhus, 2008), and therefore requires 
further investigation and particularly consideration in clinical practice. This is not just 
important for validating psychometric tools in specific countries but also in assessing for 
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depression in countries with large culturally and linguistically diverse populations, such as 
Australia, the United Kingdom and the United States of America. This is likely to become of 
increasing importance as emphasis is placed on the influence of depression on the illness 
trajectory. Therefore, further cross-validation studies are needed to test the CDS against a 
clinical interview by an experienced/trained health expert. Appreciating the cultural 
dimension may also be important in determining the individual’s attribution of causality and 
treatment options. This may influence interpersonal relationships and the interaction with 
treating clinicians. 
The results of this study showed I-CDS to be moderately correlated with the BDI, with a 
similar value to the correlation values reported by Hare and Davis (Hare & Davis, 1996), 
Birks et al. (Birks et al., 2004) and Di Benedetto et al. {1,  #6}. In addition, consistent with 
findings from the previous studies (Birks et al., 2004; Hare & Davis, 1996; Wise et al., 2006), 
the I-CDS showed a normal distribution of scores indicating the greater sensitivity of the scale 
to both extremes of scores compared to the BDI scores, which makes the I-CDS as a useful 
scale to measure depression in cardiac patients who are more likely to suffer from mild 
depression which may have an adverse impact on their recovery from a cardiac event (Astin et 
al., 2005; Irvine et al., 1999). Although slightly lower than those reported in the previous 
studies (Birks et al., 2004; Hare & Davis, 1996; Hare et al., 2000; Wise et al., 2006), this 
study demonstrated acceptable internal consistency for the overall I-CDS (Hare & Davis, 
1996). The results of factor analysis using the same extraction procedure as reported by 
previous studies suggest that the factor structure of I-CDS supports the findings of the original 
study, further supporting the two-dimension structure of the CDS, labelled as A and B by 
Hare and Davis (Hare & Davis, 1996). 
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This study has shown that the CDS is a valid tool for assessing depression in cardiac patients. 
The CDS can also facilities studying subtle trends in depression in cardiac patients and 
monitoring depression over time (Frasure-Smith & Lespérance, 2006). Effective management 
of depression has a potential to help patients cope better with their disease and comply with 
medical recommendations (Ziegelstein et al., 2000). This underscores the importance of 
screening for and treating depression in the acute care setting. The usefulness of the CDS for 
outcome measurement such as response to treatment or effectiveness of interventions such as 
cardiac rehabilitation programs should be addressed by further studies.  
Further, the answer of timing of assessment and initiation of management of depressive 
symptoms in heart disease remains elusive and further investigation is warranted given the 
burden of this problem. Participants were recruited from an acute care setting in which cardiac 
patients are more likely to experience “adjustment disorder with depressed mood”. For 
example, in a study about half of patients had major or minor depression one week after 
experiencing myocardial infarction and one third met the criteria 3 to 4 months later 
(Schleifer et al., 1989). It is also likely that depression may have preceded the development of 
heart disease in some participants. 
Conclusion 
Depression is increasingly recognised as influencing outcomes in individuals with heart 
disease. The study has shown that the I-CDS is a sensitive, reliable and valid disease-specific 
scale to screen for depression. Further cross-validation studies are advised to test I-CDS 
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Table 1 Factor loadings: A six-factor extraction of the I-CDS (Principal Components with Varimax rotation)  
Items Anhedonia Sleep Mood Suicide  Fear Cognition 
19R. I gain just as much pleasure from leisure activities as I used to (Anhedonia) .77      
4R.  I get pleasure from life at present (Anhedonia) .74      
3.  I can't be bothered doing anything much (Anhedonia) .60      
23R.  I feel independent and control in my life (Anhedonia) .46      
1.  I have dropped many of my interests and activities (Anhedonia) .37      
7.  My sleep is restless and disturbed (Sleep)  .75     
9.  I wake up in the early hours of the morning and cannot get back to sleep (Sleep)  .69     
8.  I am not the person I used to be (Anhedonia) .35      
6.  I may not recover properly (Fear)    .30 .21  
16.  I get hardly anything done (Anhedonia) .38      
21.  I become tearful more easily than before (Mood)   .83    
22.  I seem to get more easily irritated by others than before (Anhedonia) .21  .76    
24.  I lose my temper more easily nowadays (Mood)   .62    
17.  My problems are not yet over (Fear)   .46  .25  
11.  Dying is the best solution for me (Suicide)    .76   
14.  There is no misery in the future for me (Suicide)    .69   
18.  Things which I regret most about my life are bothering me (Mood)   .30    
12R.  I feel in good spirits (Suicide)    .53   
25.  I feel frustrated (Mood)   .41    
13.  The possibility of sudden death worries me (Fear)     .71  
5.  I am concerned about the uncertainty of my health (Fear)     .65  
26.  I am concerned about my capacity for sexual activity (Fear)     .62  
10.  I feel like I’m living on borrowed time (Fear)     .41  
2R. My concentration is as good as it ever was (Cognition)      .77 
15R. My mind is as fast and alert as always (Cognition)      .70 
20R. My memory is as good as it always was (Cognition)      .48 
Cronbach’s alpha .80 .62 .74 .73 .68 .58 
 Factor loading <.30 
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Table 2 Factor loadings of a two-factor extraction of the I-CDS*  
 (Maximum Likelihood with Oblimin rotation) 
 
   Factor Loadings 
  
Factor A: 






, Cognition   
22. I seem to get more easily irritated by others than before (Mood) .70  
21.  I become tearful more easily than before (Mood) .67  
25.  I feel frustrated (Mood) .65  
16.  I get hardly anything done (Inactivity) .63  
14.  There is no misery in the future for me (Hopelessness) .61  
17.  My problems are not yet over (Uncertainty) .60  
8.  I am not the person I used to be (Uncertainty) .56  
1.  I have dropped many of my interests and activities (Inactivity) .56  
7.  My sleep is restless and disturbed (Sleep) .54  
6.  I may not recover properly (Uncertainty) .53  
24.  I lose my temper more easily nowadays (Mood) .52  
10.  I feel like I’m living on borrowed time (Hopelessness) .44  
5.  I am concerned about the uncertainty of my health (Uncertainty) .43  
13. The possibility of sudden death worries me (Uncertainty) .42  
9.  I wake up in the early hours of the morning and cannot get back to sleep 
(Sleep) .41  
3.  I can't be bothered doing anything much (Inactivity) .40  
11.  Dying is the best solution for me (Hopelessness) .36  
26. I am concerned about my capacity for sexual activity (Mood) .35  
18. Things which I regret most about my life are bothering me (Uncertainty) .30  
20R.  My memory is as good as it always was (Cognition)  .62 
12R.  I feel in good spirits (Anhedonia)  .57 
15R.  My mind is as fast and alert as always (Cognition)  .44 
19R.  I gain just as much pleasure from leisure activities as I used to (Anhedonia)  .43 
4R.  I get pleasure from life at present (Anhedonia)  .42 
2R.  My concentration is as good as it ever was (Cognition)  .34 
23R.  I feel independent and control in my life (Cognition)  .32 
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BDI cutoff: >10 BDI cutoff: >18 
Sensitivity 1 - Specificity Sensitivity 1 - Specificity 
39.0 1.00 1.00 1.00 1.00 
49.0 .99 .95 1.00 .97 
60.0 .99 .79 1.00 .88 
70.5 .97 .67 1.00 .79 
80.5 .93 .56 .99 .70 
90.5 .85 .39 .94 .55 
100.5 .68 .25 .81 .37 
110.5 .51 .08 .66 .20 
120.5 .32 .05 .46 .09 
131.0 .20 .01 .31 .04 
140.5 .07 .00 .12 .01 
151.0 .04 .00 .08 .00 
161.0 .01 .00 .01 .00 
 
 




Figure 1  ROC curves for detection by CDS for mild to moderate (BDI > 10) and 
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Table 4 The percentages of patients with mild/moderate and severe depression 
according to the I-CDS and BDI 
 
Not depressed Mild/Moderate depression Severe depression 
I-CDS≤ 90 BDI≤ 10 90 <I-CDS<100  10<BDI<18 I-CDS≥ 100 BDI≥ 18 
30% 38% 17% 26% 53% 36% 
 
 
